Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Lancet Child Adolesc Health. 2023 Aug 24;7(10):708–717. doi: 10.1016/S2352-4642(23)00174-8

Figure 1: Trial profile.

Figure 1:

All liveborn infants with a tuberculosis infection test result at 44 weeks of life (at least one of IGRA or TST) were included in the analysis. IGRA=interferon-γ release assay. TST=tuberculin skin test.